Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies

被引:14
作者
Cook, RF [1 ]
Cook, SJ
Bolin, PS
Howe, LJ
Zhou, WS
Montelaro, RC
Issel, CJ
机构
[1] Univ Kentucky, Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40546 USA
[2] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
关键词
EIAV; DNA vaccine; codon-optimization;
D O I
10.1016/j.vetmic.2005.04.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the context of DNA vaccines the native equine infectious anemia virus (EIAV)-envelope gene has proven to be an extremely weak immunogen in horses probably because the RNA transcripts are poorly expressed owing to an unusual codon-usage bias, the possession of multiple RNA splice sites and potential adenosine-rich RNA instability elements. To overcome these problems a synthetic version of sequences encoding the EIAV surface unit (SU) envelope glycoprotein was produced (SYNSU) in which the codon-usage bias was modified to conform to that of highly expressed horse and human genes. In transfected COS-1 cell cultures, the steady state expression levels of SYNSU were at least 30-fold greater than equivalent native SU sequences. More importantly, EIAV-specific Immoral and lymphocyte proliferation responses were induced in ponies immunized with a mammalian expression vector encoding SYNSU. However, these immunological responses were unable to confer protection against infection with a virulent EIAV strain. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 37
页数:15
相关论文
共 60 条
[11]  
COOK RF, 1996, VIRUS INFECTIONS EQU, P295
[12]  
CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219
[13]   LENTIVIRUS ENVELOPE SEQUENCES AND PROVIRAL GENOMES ARE STABILIZED IN ESCHERICHIA-COLI WHEN CLONED IN LOW-COPY-NUMBER PLASMID VECTORS [J].
CUNNINGHAM, TP ;
MONTELARO, RC ;
RUSHLOW, KE .
GENE, 1993, 124 (01) :93-98
[14]   West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays [J].
Davis, BS ;
Chang, GJJ ;
Cropp, B ;
Roehrig, JT ;
Martin, DA ;
Mitchell, CJ ;
Bowen, R ;
Bunning, ML .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4040-4047
[15]   Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein [J].
Deml, L ;
Bojak, A ;
Steck, S ;
Graf, M ;
Wild, J ;
Schirmbeck, R ;
Wolf, H ;
Wagner, R .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10991-11001
[16]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Liu, MA .
LIFE SCIENCES, 1996, 60 (03) :163-172
[17]   Rabies DNA vaccine in the horse: strategies to improve serological responses [J].
Fischer, L ;
Minke, J ;
Dufay, N ;
Baudu, P ;
Audonnet, JC .
VACCINE, 2003, 21 (31) :4593-4596
[18]   Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination [J].
Fuller, DH ;
MurpheyCorb, M ;
Clements, J ;
Barnett, S ;
Haynes, JR .
JOURNAL OF MEDICAL PRIMATOLOGY, 1996, 25 (03) :236-241
[19]   Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus [J].
Giese, M ;
Bahr, U ;
Jakob, NJ ;
Kehm, R ;
Handermann, M ;
Müller, H ;
Vahlenkamp, T ;
Spiess, C ;
Schneider, T ;
Schusser, G ;
Darai, G .
VIRUS GENES, 2002, 25 (02) :159-167
[20]   Codon usage limitation in the expression of HIV-1 envelope glycoprotein [J].
Haas, J ;
Park, EC ;
Seed, B .
CURRENT BIOLOGY, 1996, 6 (03) :315-324